On October 27, 2016, MAPS Public Benefit Corporation (MPBC) staff met with investigators in Charleston, South Carolina for the formal closeout of our largest Phase 2 study of MDMA-assisted psychotherapy in 24 U.S. veterans, firefighters, and police officers with chronic, treatment-resistant PTSD. Conducted by Clinical Trial Leaders Rebecca Matthews and Alli Feduccia, Ph.D., the closeout included a thorough review of the study’s documentation, database, files, and adherence to regulations. All treatment sessions and long-term follow-up interviews for this study have now been completed. Led by Principal Investigator Michael Mithoefer, M.D., and Co-investigator Annie Mithoefer, B.S.N., in Charleston, South Carolina, the data from this study are now being prepared for analysis and publication in a peer-reviewed scientific journal. Learn more…
